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1. Introduction 
The synthesis of the tripeptide pyroglutamyl- 
histidyl-prolineamide (TRF), the thyreotropin 
releasing factor [ 1,2], and its labelling [3] have 
promoted studies of its mode of action at the mole- 
cular level [4]. One important step towards this aim 
is to define the shape of the molecule and the relation- 
ships between biological activity and conformations. 
For this purpose ‘H-NMR investigations of TRF and 
related peptides have been carried out. The conforma- 
tion of the histidyl residue was deduced from the 
relationships between the vicinal coupling constant 
J (NH-CctH) and the dihedral angle (C&H-NH). @ 
was derived from the equation 8 = (O-60) [5-S]. 
The behaviour of the C&H-CPH, histidyl protons and 
the non equivalence of the two prolyl C6 protons, on 
one hand, the differences between the cis and the 
trans-protons of the terminal amide group on the 
other hand suggested additional ~onformational 
restrictions. On this basis a model of TRF conforma- 
tion is presented. 
2. Material and methods 
TRF was a gift of Dr. R-0. Studer (Hoffman-La 
Roche, Basel). The tetrapeptide Val-His-Pro-Phe 
was kindly provided by Dr. Riniker (Ciba-Geigy, Basel). 
The dipeptide Pro-Phe, the amino acids L-proline, 
L-pyroglutamic acid and L-histidine, were from Sigma. 
Spectra were run on a TSN 250 MHz (Cameca) and 
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PS 100 MHz (Jeol) spectrometers. Assignment of the 
protons was realized with the double resonance 
technique (proton-proton decoupIing) and by 
comparison with the free amino acids and related 
peptides spectra. 
The probe temperature was maintained to -+l”. 
TMS was used as internal or external reference and 
chemical shifts are defined on 6 scale in ppm. Studies 
were performed on 0.05 to 0.1 M sample solutions. 
3. Results 
The assignments of the chemical shifts of TRF and 
of some of the related compounds are reported in 
table 1. A typical spectrum is shown in fig. I, where 
bridges indicate resonance patterns connected by 
decoupling. 
The tram and cis proton signals belonging to the 
terminal CONH, are located, respectively, at 7.94 and 
6.89 ppm. The chemical shift difference observed 
(1 .OS ppm) between the cis and tram protons is large 
when compared to the values reported for acetamide 
and propionamide, (0.60 and 0.55 ppm) [9] or 
observed for the Asn 0 CONH, of angiotensinamide 
II (0.60 ppm) [lo]. The imidazole C,H and C,H 
resonances are found at 7.5 1 ppm and 6.89 ppm. Thus 
the imidazole C, proton overlaps with the cis CONH, 
proton signal. The chemical shifts of these two 
imidazole protons are nearly the same as for their 
homologs in Val-His-Pro-Phe. Their peaks are sharp 
when the TRF is dissolved in dry DMSO. However, 
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Table 1 
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TRF proton assignments and comparison with several related compounds chemical shifts, TMS as external or internal references. 
w N-H cPH C* C&H Other compounds 
PCA 
His 
~ 
Pro 
4.64 8.07 2.89 
4.68 8.46 3.10 
3.85 
4.07 
4.22 
4.33 
4.59 cis 
4.39 tram 
4.25 
7.77 1.82 
2.20 
7.82 1.86 
2.24 
3.13 
3.19 
2.10 
1.82 
1.60 
1.80 
= 2.10 
= 2.10 
1.90 
2.35 
2.10 
2.10 
1.82 3.51 
3.23 
1.80 3.59 
2 3.30 
2 2.10 3.47 
= 2.10 3.47 
1.90 3.35 
(6) 
C2H 7.51 
C4H 6.89 
C2H 7.52 (1) 
C4H 6.88 
CzH 7.71 (4) 
C4H 7.01 
C2H 8.06 (5) 
C4H 6.14 
_N,Hcis 6.89 
‘Htrans 7.94 
(1) 
(2) 
(3) 
(I) Val-His-Pro-Phe/DMSO, 20”. (2) ~acetyl-proline/D20,40”, neutral pH, from McDon~d and Phillips. (3) Pro-Phe/DzO, 
20”) neutral pH. (4) Histidine/D*O, 20*, neutral pH. (5) L-His-L-Leu/DzO, 40”, neutral pH, from MC Donald and Phillips. 
(6) PCA/DMSO, 20’. 
when a drop of water is added to the solution, the 
C,H signal broadens whereas the C,H signal remains 
unchanged. Moreover, one observes at about 12 ppm, 
a broad assigned.to the imidazole NH resonance, and 
of course at about 3.4 ppm the very intense water 
peak. A correlation between these two peaks had 
been establi~ed with double resonance technique. 
The amide cyclic proton of the pyroglutamyl 
residue appears as a singlet at 7.77 ppm and irradiation 
in the Cd_r area (4.04 ppm) does modify only its 
intensity. Comparison with the free pyroglutamic 
acid spectrum recorded in the same conditions shows 
no significant difference in signal positions without 
or with irradiation experiments. 
The doublet at 8.07 ppm for which a coupling 
constant of 7.5-8 Hz is measured, belongs to the 
histidyl amide proton signal, Upon irradiation at 
4.64 ppm this doublet coalesces as a singlet. It should 
be noted that histidyl amide resonance in 
V~-His-Pro-Phe is located more down~eld, at 
8.46 ppm. In the C,H area the muItiplet at 4.64 ppm 
assigned to the histidyl C,H is transformed upon 
irradiation of the NH doublet in a triplet (X part of 
an ABX system) with a coupling constant of about 6 H 
corresponding to JC, H-CpHA, nearly equal to E, H- 
CpHB. With double resonance technique the AB part 
(histidyl C& centered at 2.89 ppm) of the ABX 
system, is changed to a very well defined quadruplet 
with JC cHA nearly equal to 16 Hz. By using the 
Pachier kl&ption [ 111 and the values proposed by 
Abraham and McLau~an [12], we can determine that 
the mole fraction of the staggered conformer (fig. 2b) 
could be present at about 3%. This means that this 
conformation which would appear to be least favored 
sterically is slightly stabilized. 
Decoupling measurements and comparison with the 
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pro CONH, 
Fig. 1. 250 MHz *H-NMR spectrum of TRF dissolved in d6 DMSO at 20”. Bridges indicate the coupled protons as determined by 
irradiation. 
his. NH 
)$: 
his.CO 
-. 
*. -i mid. 
(a) (b) 
Fig. 2. (a) A proposed model for TRF (PCA-His-Pro-NH2). (b) A preferential conformation of His side chain. 
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spectra of free amino acids and related compounds, 
lead to the assignments of prolyl. C,H’(4.22 ppm), 
C& (2.10 and 1.82 ppm), C& (1.82 ppm) and 
pyroglutamyl C,H (4.04 ppm), CpH (1.82 and 2.20 
ppm) in spite of the overlapping of the upfield peaks. 
Finally, an important feature concerns the two 
quadruplets observed at 3.57 ppm for the propyl 
CsH,. Such a pattern is also found in the Val-His- 
Pro-Phe spectrum but never in that given by proline 
alone. 
3. Discussion 
Let us first consider the peptide backbone: the 
dihedral angle corresponding to the C,H-NH coupling 
constant JC,H-NH (7.5-8 Hz) for histidine has been 
derived on the basis of Bystov et al. [ 131 calculations 
and empirical curves, and from Gibbons et al. [7] 
and Ramachandran et al. [6] work on peptide con- 
formations. To choose between the three possibilities 
offered for Cp, -ISO”, -90” and +60°, Dreiding models 
have been made. Maximum stability is found for 
@ = -150”. In this case, interaction between N’ im* 
and the histidyl amide proton might be possible if 
the side chain of this residue is in the staggered con- 
formation seen above (fig. 2b). Evidences from the 
literature are in agreement with this preferential con- 
formation a) the observation of an anomalous pK 
(6.25) for the imidazole ring [ 141, b) a loss or a 
potentialization of the biological activity, respectively, 
for Ni im. Me-TRF and N3 im. Me-TRF [ 151. This in- 
dicates a probable involvement of the N1 im. in a 
hydrogen bond and confers to this nitrogen an impor- 
tant structural role. 
The C-terminal amide protons yielded two separate 
signals (A& cis-tram = 1.05 ppm). The anomalous 
downfield shift of the trans proton seems to indicate 
some interaction. It has long been recognized that 
protons involved in a hydrogen bond exhibit a very 
marked deshielding [ 16-181. In the case of TRF, 
ex~ination of the molecule suggests ~mediately a 
hydrogen bonding involving both the trans C-terminus 
amide proton and the histidyl carbonyl group. In this 
situation with the prolyl residue in trans configuration, 
a stable equatorial seven-membered ring is created 
[ 19-2 I]. Such a conformation would produce a lock 
of the prolyl residue. Moreover the two signals given 
by the prolyl C&H, indicate a high asymmetry at the 
ring level and could be the result of the nitrogen free 
doublet upfield effect on the axial anticoplanar C6 
proton [22]. 
The pyroglutamyl NH is not involved in a hydrogen 
bond and this result is in agreement with those 
reported [ 141 showing that N-Me PCA-His-Pro-NH, 
presents no modi~cation of the imidazole pK. 
The last observation is the broadening of the 
imidazole C,H signal only, without change of the 
C,H signal, in presence of water. This phenomenon 
is not yet clearly understood, and is upon investiga- 
tion. The proton exchange occurring between the 
nitrogen and a water molecule could be responsible 
for the modification observed. 
4. Conclusion 
The TRF model proposed here (fig. 2a) presents 
as essential features two hydrogen bonds: the first 
holds the imidazole ring of histidyl in a well defined 
orientation (maybe in relation with the biological 
activity). The second hydrogen involving one C-ter- 
minal CONH, proton and the histidyl carbonyl group, 
stabilizes the peptide backbone de~ning a seven 
membered-ring. Interesting is the comparison with 
the results obtained for the octapeptide angiotensine 
II and Val-His-Pro-Phe [lo] which both exhibit 
a hydrogen bond between the C-terminal phenyl- 
alanine NH and the histidyl carbonyl group. This 
would mean that in even short peptides a stabilizing 
event could occur around the propyl residue. If this 
generalization would be true it would account for 
the essential role of proline in a variety of biologic~ly 
active peptides. Thus, it could well be that the 
resulting conformations correspond to structural 
requirements associated with the characteristics of 
more than a few types of receptor sites. 
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